Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

PhycoBiologics Inc (AKA: Phyco Biologics Inc~Phycotransgenics LLC~PBI)
Profile last edited on: 1/6/16      CAGE: 37WK7      UEI:

Business Identifier: Algae-based oral vaccine production and delivery systems
Year Founded
2000
First Award
2001
Latest Award
2012
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

3416 Ashwood Drive
Bloomington, IN 47401
   (812) 339-3057
   N/A
   www.phycotransgenics.com
Location: Multiple
Congr. District: 09
County: Monroe

Public Profile

PhycoBiologics Inc. is a biotechnology company specializing in the development of alae-based biological delivery systems. The patented technology allows for the production and delivering of biologically active protieins to humans and animals using microalgae. Products include vaccines, growth peptides, adjuvants, and emzymes. PhycoBiologics is the sole owner of its subsidiary Phycotransgenics LLC.

Extent of SBIR involvement

User Avatar
Phase I Awards
7
Phase II Awards
1
Conversion Rate
14.29%
Phase I Dollars
$554,955
Phase II Dollars
$199,650
Total Awarded
$754,605

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2012 1 USDA $100,000
Project Title: Novel low cost extraction of algal oils used in fish feeds
2008 1 USDA $80,000
Project Title: Novel Algaecide for Control of Off-Flavor in Catfish Ponds
2004 1 NIH $100,000
Project Title: Microalgal Oral Vaccines for Control of Amebiasis
2003 1 USDA $75,000
Project Title: Development of a Microalgal-Based Oral Vaccine Delivery System for Poultry
2002 1 NSF $99,955
Project Title: Microalgal Vaccines for the Control of White Spot Syndrome Virus in Shrimp

Key People / Management

  Richard E Wagner -- CEO

  Richard T Sayre

Company News

Sep 18 2007
First Venture Accelerates Commercialization Process Thru Acquisition of PhycoBiologics Inc